Press release 📈 Stocks 🌍 United States

Triquetra Health Launches Folura Supplement Featuring 160 mg Saw Palmetto

Triquetra Health expands its product portfolio with the launch of Folura, a new supplement featuring a standardized 160 mg dose of Serevelle saw palmetto, now available via Amazon.

🕐 1 min read

1 assets impacted. Net bias: 0 Bullish, 0 Bearish, 1 Neutral. Strongest signal: Triquetra Health → 1/10 (55% confidence).

📊 Affected Assets (1)

Triquetra Health
Neutral 🤖 55%
📅 Short-term 🌍 US · Explicit

Triquetra Health announced the launch of its Folura supplement with Serevelle saw palmetto, a routine product launch press release with no significant market impact.

🎯 Key Takeaways

  • Folura supplement utilizes a 160 mg dose of Serevelle saw palmetto.
  • The product is currently available for purchase through Amazon.
  • Triquetra Health maintains its focus on single-active formulations and label transparency.

📝 Executive Summary

Triquetra Health has officially released its new Folura supplement, which incorporates Serevelle saw palmetto at a 160 mg dosage. The product is now available for purchase on Amazon, targeting both men and women with a focus on single-active formulation and label transparency.

❓ FAQ

What is the primary active ingredient in the new Folura supplement?

The supplement features Serevelle saw palmetto at a 160 mg dosage, consistent with amounts used in randomized clinical trials.